MedTrace Logo

High Flow Nasal Cannula Oxygen During Sedation for Video-assisted Thoracoscopic Surgery

NCT04520568 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-08-20

No results posted yet for this study

Summary

High-flow nasal cannula (HFNC) is a device that delivers10 to 70 L min-1 of heated, humidified 100% oxygen via nasal route. It provides positive airway pressure, decreases dyspnea, decreases the work of breathing, and improves comfort

Conditions

Interventions

COMBINATION_PRODUCT

High flow nasal cannula

using sedation with the HFNC F\&P AIRVOTM 2 to maintain oxygenation

COMBINATION_PRODUCT

CONTROL

using general anaesthesia with one lung ventilation (OLV) technique

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Rehab A. Abd Elaziz, Ass.Prof. · Alexandria University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2020-11-10
Completion
2020-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04520568 on ClinicalTrials.gov